Evaluation of Antibacterial Soap for Treatment of Lymphedema in a Filariasis-Endemic Area

Not Applicable

Completed

• Conditions: Cellulitis; Lymphedema

• Registration Number: NCT00139100
• Lead Sponsor: Centers for Disease Control and Prevention

Brief Summary

Introduction. Lymphatic filariasis is a devastating mosquito-transmitted parasitic disease that causes lymphedema or elephantiasis of the leg in 15 million persons, the majority of whom are women. In these persons, frequent bacterial infections ("acute attacks") of the legs adversely affect physical health, economic well-being, and quality of life. Prevention of bacterial infections through hygiene and skin care can result in significant improvements in lymphedema and patient well-being.

Methods. To determine the extent to which antibacterial soap can help reduce the incidence of acute bacterial infections of the lower limbs in persons with filarial lymphedema, 200 patients of the Ste. Croix Hospital lymphedema treatment clinic in Leogane, Haiti randomly assigned to receive either antibacterial (Safeguard) or placebo (Camay) soap and acute attacks monitored monthly for 12 months. Both groups received specific instructions on washing and skin care.

Detailed Description

Not available

Study Timeline

• Study Start: 2001-02
• Study Completion: 2002-03
• Status Verified: 2005-08
• Study First Submitted: 2005-08-29
• Study First Submitted QC: 2005-08-29
• Study First Posted: 2005-08-31
• Last Update Submitted: 2008-10-23
• Last Update Posted: 2008-10-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Patients eligible for participation include those who are currently enrolled in the lymphedema treatment program in Leogane who 1) have been trained in the techniques of self-care, 2) who live in a 10-km radius of the hospital, and 3) for whom we have adequate data on incidence of acute bacterial infections, risk factors for infection, and ability to comply with the treatment protocol (particularly hygiene).

Exclusion Criteria

Don't meet inclusion criteria.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Reported or observed severity of these acute attacks.
Incidence of bacterial "acute attacks", assessed monthly.
Duration of acute attacks.

Secondary Outcome Measures

Name	Time	Method
Demonstrated knowledge and ability to wash leg appropriately during home visits.
Number of bars of soap used per patient per month.
Reported patient satisfaction with soap.
Process measures
Reported frequency of leg washing.

Trial Locations

Locations (1)

Hopital Ste. Croix; 🇭🇹 Leogane, Haiti